Cognitive and motor effects of dopaminergic medication withdrawal in Parkinson’s disease
暂无分享,去创建一个
[1] C. Marsden,et al. l-Dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction , 2005, Psychopharmacology.
[2] T. Robbins,et al. Impaired set-shifting and dissociable effects on tests of spatial working memory following the dopamine D2 receptor antagonist sulpiride in human volunteers , 2004, Psychopharmacology.
[3] Peter Ford Dominey,et al. Dissociable effects of dopaminergic therapy on spatial versus non-spatial working memory in Parkinson’s disease , 2003, Neuropsychologia.
[4] C. Caltagirone,et al. Dopaminergic Modulation of Visual-Spatial Working Memory in Parkinson’s Disease , 2003, Dementia and Geriatric Cognitive Disorders.
[5] B. Dubois,et al. Motivation, reward, and Parkinson’s disease: influence of dopatherapy , 2002, Neuropsychologia.
[6] D. V. Cramon,et al. Manipulation of working memory information is impaired in Parkinson's disease and related to working memory capacity. , 2002, Neuropsychology.
[7] A. Nieoullon. Dopamine and the regulation of cognition and attention , 2002, Progress in Neurobiology.
[8] T. Robbins,et al. Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PET. , 2002, Brain : a journal of neurology.
[9] T. Robbins,et al. Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands. , 2001, Cerebral cortex.
[10] J. Missimer,et al. Reward mechanisms in the brain and their role in dependence: evidence from neurophysiological and neuroimaging studies , 2001, Brain Research Reviews.
[11] T. Sawaguchi,et al. The effects of dopamine and its antagonists on directional delay-period activity of prefrontal neurons in monkeys during an oculomotor delayed-response task , 2001, Neuroscience Research.
[12] S Fahn,et al. Committee. Unified Parkinson’s Disease Rating Scale. , 2001 .
[13] T. Robbins,et al. Probabilistic learning and reversal deficits in patients with Parkinson’s disease or frontal or temporal lobe lesions: possible adverse effects of dopaminergic medication , 2000, Neuropsychologia.
[14] J. Roulin,et al. Working memory functioning in medicated Parkinson's disease patients and the effect of withdrawal of dopaminergic medication. , 2000, Neuropsychology.
[15] T. Robbins,et al. The effect of dopamine depletion from the caudate nucleus of the common marmoset (Callithrix jacchus) on tests of prefrontal cognitive function. , 2000, Behavioral neuroscience.
[16] P. Pollak,et al. The relation of putamen and caudate nucleus 18F-Dopa uptake to motor and cognitive performances in Parkinson’s disease , 1999, Journal of the Neurological Sciences.
[17] Phan Luu,et al. Mood and spatial memory: emotion and right hemisphere contribution to spatial cognition , 1999, Biological Psychology.
[18] W. Schultz,et al. Relative reward preference in primate orbitofrontal cortex , 1999, Nature.
[19] J. Baron,et al. Relationships between striatal dopamine denervation and frontal executive tests in Parkinson's disease , 1999, Neuroscience Letters.
[20] J. Hollerman,et al. Reward prediction in primate basal ganglia and frontal cortex , 1998, Neuropharmacology.
[21] J. Gray,et al. Increased extracellular dopamine in the nucleus accumbens of the rat during associative learning of neutral stimuli , 1998, Neuroscience.
[22] B. Postle,et al. The time course of spatial and object learning in Parkinson's disease , 1997, Neuropsychologia.
[23] Monica Luciana,et al. Dopaminergic Modulation of Working Memory for Spatial but Not Object Cues in Normal Humans , 1997, Journal of Cognitive Neuroscience.
[24] J Jonides,et al. Spatial, but not object, delayed response is impaired in early Parkinson's disease. , 1997, Neuropsychology.
[25] T. Robbins,et al. Spatial and non-spatial working memory at different stages of Parkinson's disease , 1997, Neuropsychologia.
[26] K Wienhard,et al. Functional effects of striatal dysfunction in Parkinson disease. , 1997, Archives of neurology.
[27] J. Kulisevsky,et al. Acute effects of levodopa on neuropsychological performance in stable and fluctuating Parkinson's disease patients at different levodopa plasma levels. , 1996, Brain : a journal of neurology.
[28] Adrian M. Owen,et al. Dopamine-Dependent Frontostriatal Planning Deficits in Early Parkinson's Disease , 1995 .
[29] J. Fermanian,et al. Mini-Mental Parkinson: first validation study of a new bedside test constructed for Parkinson's disease. , 1995, Behavioural neurology.
[30] P. Rabbitt,et al. Cambridge Neuropsychological Test Automated Battery (CANTAB): a factor analytic study of a large sample of normal elderly volunteers. , 1994, Dementia.
[31] P. Goldman-Rakic,et al. The role of D1-dopamine receptor in working memory: local injections of dopamine antagonists into the prefrontal cortex of rhesus monkeys performing an oculomotor delayed-response task. , 1994, Journal of neurophysiology.
[32] Y. Agid,et al. Delayed response tasks and prefrontal lesions in man—Evidence for self generated patterns of behaviour with poor environmental modulation , 1993, Neuropsychologia.
[33] T. Robbins,et al. Contrasting mechanisms of impaired attentional set-shifting in patients with frontal lobe damage or Parkinson's disease. , 1993, Brain : a journal of neurology.
[34] J. Hedreen,et al. The locus ceruleus and dementia in Parkinson's disease , 1993, Neurology.
[35] Y. Agid,et al. Explicit memory in Alzheimer's, Huntington's, and Parkinson's diseases. , 1993, Archives of neurology.
[36] Werner Paulus,et al. Clinico-pathological correlations in Parkinson's disease , 1992, Clinical Neurology and Neurosurgery.
[37] C. Marsden,et al. Fronto-striatal cognitive deficits at different stages of Parkinson's disease. , 1992, Brain : a journal of neurology.
[38] O. Wolkowitz,et al. Measurement and interpretation of changes in memory in response to drug treatments. , 1992, Psychopharmacology bulletin.
[39] R. Depue,et al. Facilitation of Working Memory in Humans by a D2 Dopamine Receptor Agonist , 1992, Journal of Cognitive Neuroscience.
[40] P. Goldman-Rakic,et al. D1 dopamine receptors in prefrontal cortex: involvement in working memory , 1991, Science.
[41] J. Jankovic,et al. Variable expression of Parkinson's disease , 1990, Neurology.
[42] J. Saint-Cyr,et al. Memory and learning in early Parkinson's disease: Evidence for a “frontal lobe syndrome” , 1990, Brain and Cognition.
[43] L. Henderson,et al. Antisaccades and remembered saccades in Parkinson's disease. , 1990, Journal of neurology, neurosurgery, and psychiatry.
[44] W. Gibb,et al. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. , 1988, Journal of neurology, neurosurgery, and psychiatry.
[45] S. Kish,et al. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. , 1988, The New England journal of medicine.
[46] C. Marsden,et al. 'Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off' levodopa. , 1988, Brain : a journal of neurology.
[47] V. Mountcastle,et al. Higher functions of the brain , 1987 .
[48] S. Fahn. Unified Parkinson's Disease Rating Scale , 1987 .
[49] D. Price,et al. Cellular pathology in Alzheimer's and Parkinson's diseases , 1986, Trends in Neurosciences.
[50] J. Saint-Cyr,et al. Frontal lobe dysfunction in Parkinson's disease. The cortical focus of neostriatal outflow. , 1986, Brain : a journal of neurology.
[51] G. E. Alexander,et al. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. , 1986, Annual review of neuroscience.
[52] A. Lees,et al. Cognitive deficits in the early stages of Parkinson's disease. , 1983, Brain : a journal of neurology.
[53] H. E. Rosvold,et al. Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. , 1979, Science.
[54] M. M. Burns,et al. Parkinsonism , 1975, Neurology.
[55] William G. Cochran,et al. Experimental Designs, 2nd Edition , 1950 .